NR promotes liver regeneration after PVE in obese rats by enhancing NAD+-dependent metabolic pathways through the MCART1/ASB3 axis, offering a potential therapeutic strategy for obesity-associated liver dysfunction. Here, SLC25A51 is linked to obesity due to melanocortin 4 receptor deficiency.